NCT05478460 is a clinical trial of Hookwire localization in Lung Cancer, sponsored by Fudan University.

Who is sponsoring NCT05478460?

NCT05478460 is sponsored by Fudan University.

What drugs are being tested in NCT05478460?

Interventions in NCT05478460: Hookwire localization.

What condition does NCT05478460 study?

NCT05478460 studies Lung Cancer.

Is NCT05478460 still recruiting?

NCT05478460 is currently completed. Last updated 24 October 2022.

Last reviewed 2022-10-24 · How we verify

NCT05478460

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute and Chronic Pain After Video-assisted Thoracoscopic Surgery for Lung Cancer

Completed Last updated 24 October 2022

What this trial tests

trial testing Hookwire localization in Lung Cancer in 161 participants. Completed in 21 July 2022.

Timeline

10 August 2021

Primary endpoint
21 July 2022

21 July 2022

Quick facts

Lead sponsor	Fudan University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	161
Start date	10 August 2021
Primary completion	21 July 2022
Estimated completion	21 July 2022
Sites	1 location across China

Drugs / interventions tested

Hookwire localization

Conditions studied

Lung Cancer — all drugs for Lung Cancer →

Sponsor

Fudan University

Who can join

Adults 18 to 75, any sex, with Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to evaluate whether preoperative CT- guided hookwire localization would influence the incidence and intensity of acute and chronic pain after VATS.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Does Preoperative Hookwire Localization Influence Postoperative Acute and Chronic Pain After Video-Assisted Thoracoscopic Surgery: A Prospective Cohort Study.
Kong L, Gao L, Zhang H, Wang X, et al · · 2023 · cited 6× · PMID 36636265 · DOI 10.2147/jpr.s387543

Verify or expand the search:

Other recruiting trials for Lung Cancer

Currently open trials in the same condition.

NCT07295821 — Osimertinib Induction and Maintenance for Chemo-ineligible Stage III Unresectable EGFR+ NSCLC: Single-arm Study · Phase 2 · recruiting
NCT06909201 — Hyperpolarized Xenon-129 Magnetic Resonance Imaging in Lung Cancer Patients Receiving Radiation Therapy for Investigatin · Phase 1 · recruiting
NCT07524114 — Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception · recruiting
NCT07487064 — Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study · NA · recruiting
NCT07146568 — Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hos · NA · recruiting

Other Fudan University trials

Trials by the same sponsor.

NCT06196671 — Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer · Phase 2 · not yet recruiting
NCT07423611 — ctDNA-Guided Chemotherapy Omission With Ribociclib Plus Endocrine Therapy in HR-Positive/HER2-Negative Breast Cancer · Phase 2 · not yet recruiting
NCT07410559 — Neoadjuvant Imlunestrant Plus Abemaciclib Treatment Guided by Ki67 Index After 2 Weeks for ER-Positive HER2-Negative Bre · Phase 2 · not yet recruiting
NCT07490119 — Becotatug Vedotin Combined With Cetuximab in the Later-line Treatment of Metastatic RAS Wild-type Colorectal Cancer · Phase 2 · not yet recruiting
NCT07497919 — A Study of Becotatug Vedotin Combined With Pucotenlimab in the Treatment of EGFR-Positive Advanced Penile Cancer · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05478460 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fudan University
Last refreshed: 24 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05478460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing